Works matching Maturation inhibitors

Results: 319
    1
    2

    Antiviral Activity, Safety, and Exposure–Response Relationships of GSK3532795, a Second-Generation Human Immunodeficiency Virus Type 1 Maturation Inhibitor, Administered as Monotherapy or in Combination With Atazanavir With or Without Ritonavir in a Phase 2a Randomized, Dose-Ranging, Controlled Trial (AI468002).

    Published in:
    Clinical Infectious Diseases, 2017, v. 65, n. 3, p. 442, doi. 10.1093/cid/cix239
    By:
    • Hwang, Carey;
    • Schürmann, Dirk;
    • Sobotha, Christian;
    • Boffito, Marta;
    • Sevinsky, Heather;
    • Ray, Neelanjana;
    • Ravindran, Palanikumar;
    • Hong Xiao;
    • Keicher, Christian;
    • Hüser, Andreas;
    • Krystal, Mark;
    • Dicker, Ira B.;
    • Grasela, Dennis;
    • Lataillade, Max
    Publication type:
    Article
    3
    4
    5

    A Phase IIa Study Evaluating Safety, Pharmacokinetics, and Antiviral Activity of GSK2838232, a Novel, Second-generation Maturation Inhibitor, in Participants With Human Immunodeficiency Virus Type 1 Infection.

    Published in:
    Clinical Infectious Diseases, 2020, v. 71, n. 5, p. 1255, doi. 10.1093/cid/ciz938
    By:
    • DeJesus, Edwin;
    • Harward, Sara;
    • Jewell, Roxanne C;
    • Johnson, Mark;
    • Dumont, Etienne;
    • Wilches, Viviana;
    • Halliday, Fiona;
    • Talarico, Christine L;
    • Jeffrey, Jerry;
    • Gan, Jianjun;
    • Xu, Jianfeng;
    • Felizarta, Franco;
    • Scribner, Anita;
    • Ramgopal, Moti;
    • Benson, Paul;
    • Johns, Brian A
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13
    14

    Structural basis of HIV-1 maturation inhibitor binding and activity.

    Published in:
    Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-36569-y
    By:
    • Sarkar, Sucharita;
    • Zadrozny, Kaneil K.;
    • Zadorozhnyi, Roman;
    • Russell, Ryan W.;
    • Quinn, Caitlin M.;
    • Kleinpeter, Alex;
    • Ablan, Sherimay;
    • Meshkin, Hamed;
    • Perilla, Juan R.;
    • Freed, Eric O.;
    • Ganser-Pornillos, Barbie K.;
    • Pornillos, Owen;
    • Gronenborn, Angela M.;
    • Polenova, Tatyana
    Publication type:
    Article
    15
    16
    17
    18
    19
    20

    Safety, efficacy, and dose response of the maturation inhibitor GSK3532795 (formerly known as BMS-955176) plus tenofovir/emtricitabine once daily in treatment-naive HIV-1-infected adults: Week 24 primary analysis from a randomized Phase IIb trial.

    Published in:
    PLoS ONE, 2018, v. 13, n. 10, p. 1, doi. 10.1371/journal.pone.0205368
    By:
    • Morales-Ramirez, Javier;
    • Bogner, Johannes R.;
    • Molina, Jean-Michel;
    • Lombaard, Johan;
    • Dicker, Ira B.;
    • Stock, David A.;
    • DeGrosky, Michelle;
    • Gartland, Margaret;
    • Pene Dumitrescu, Teodora;
    • Min, Sherene;
    • Llamoso, Cyril;
    • Joshi, Samit R.;
    • Lataillade, Max
    Publication type:
    Article
    21
    22
    23
    24
    25
    26

    Phase IIa Proof-of-Concept Evaluation of the Antiviral Efficacy, Safety, Tolerability, and Pharmacokinetics of the Next-Generation Maturation Inhibitor GSK3640254.

    Published in:
    Clinical Infectious Diseases, 2022, v. 75, n. 5, p. 786, doi. 10.1093/cid/ciab1065
    By:
    • Spinner, Christoph D;
    • Felizarta, Franco;
    • Rizzardini, Giuliano;
    • Philibert, Patrick;
    • Mitha, Essack;
    • Domingo, Pere;
    • Stephan, Christoph J;
    • DeGrosky, Michelle;
    • Bainbridge, Veronica;
    • Zhan, Joyce;
    • Dumitrescu, Teodora Pene;
    • Jeffrey, Jerry L;
    • Xu, Jianfeng;
    • Halliday, Fiona;
    • Gan, Jianjun;
    • Johnson, Mark;
    • Gartland, Martin;
    • Joshi, Samit R;
    • Lataillade, Max
    Publication type:
    Article
    27
    28
    29

    Preclinical Profile of the HIV-1 Maturation Inhibitor VH3739937.

    Published in:
    Viruses (1999-4915), 2024, v. 16, n. 10, p. 1508, doi. 10.3390/v16101508
    By:
    • McAuliffe, Brian;
    • Falk, Paul;
    • Chen, Jie;
    • Chen, Yan;
    • Sit, Sing-Yuen;
    • Swidorski, Jacob;
    • Hartz, Richard A.;
    • Xu, Li;
    • Venables, Brian;
    • Sin, Ny;
    • Meanwell, Nicholas A.;
    • Regueiro-Ren, Alicia;
    • Wensel, David;
    • Hanumegowda, Umesh;
    • Krystal, Mark
    Publication type:
    Article
    30
    31
    32
    33
    34
    35
    36

    JAK inhibitors differentially modulate B cell activation, maturation and function: A comparative analysis of five JAK inhibitors in an in-vitro B cell differentiation model and in patients with rheumatoid arthritis.

    Published in:
    Frontiers in Immunology, 2023, v. 13, p. 1, doi. 10.3389/fimmu.2023.1087986
    By:
    • Frede, Natalie;
    • Lorenzetti, Raquel;
    • Hüppe, Janika M.;
    • Janowska, Iga;
    • Troilo, Arianna;
    • Schleyer, Marei-Theresa;
    • Venhoff, Ana C.;
    • Voll, Reinhard E.;
    • Thiel, Jens;
    • Venhoff, Nils;
    • Rizzi, Marta
    Publication type:
    Article
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50

    Bromodomain and extraterminal protein inhibitor JQ1 induces maturation arrest and disrupts the cytoplasmic organization in mouse oocytes under in vitro conditions.

    Published in:
    Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-025-96687-z
    By:
    • Poojary, Keerthana Karunakar;
    • Kunhiraman, Jyolsna Ponnaratta;
    • Madhvacharya, Vanishree Vasave;
    • Kumari, Sandhya;
    • Krishna, Navami;
    • S, Suresh P;
    • K, Rajanikant G;
    • Mutalik, Srinivas;
    • Ghani, Nadeem Khan;
    • Kabekkodu, Shama Prasada;
    • Prasad, Thottethodi Subrahmanya Keshava;
    • Adiga, Satish Kumar;
    • Kalthur, Guruprasad
    Publication type:
    Article